Blog
Compared to Estimates, Halliburton (HAL) Q1 Earnings: A Look at Key Metrics
Halliburton (HAL) reported $5.42 billion in revenue for the quarter ended March 2025, representing a year-over-year decline of 6.7%. EPS of $0.60 for the same period compares to $0.76 a year ago.
Okta Declines 11% in a Month: Should You Buy the Stock on the Dip?
Okta OKTA shares have declined 11% in a month, given a challenging macroeconomic environment due to higher tariffs. However, an innovative portfolio that includes Okta Identity Governance
What's in the Offing for Ventas Stock This Earnings Season?
Ventas, Inc. VTR is scheduled to report first-quarter 2025 results on April 30, after market close. The quarterly results are likely to display year-over-year growth in revenues and normalized funds
Here's What to Expect From VICI Properties in Q1 Earnings
VICI Properties Inc. VICI is slated to report first-quarter 2025 earnings results on April 30, after the closing bell. Its quarterly results are expected to exhibit growth in revenues and adjusted
Should You Invest in Bitcoin Now?
Did you know that, since its inception, Bitcoin has been the best performing asset class worldwide?In fact, at its current $1.87 trillion valuation, Bitcoin has even surpassed Alphabet (formerly
HCA Healthcare Q1 Earnings Beat on Growing Patient Volumes
HCA Healthcare, Inc. HCA reported first-quarter 2025 adjusted earnings per share (EPS) of $6.45, which outpaced the Zacks Consensus Estimate of $5.77. The bottom line advanced 20.3% year over year
Southern Copper (SCCO) Beats Q1 Earnings and Revenue Estimates
Southern Copper (SCCO) came out with quarterly earnings of $1.19 per share, beating the Zacks Consensus Estimate of $1.13 per share. This compares to earnings of $0.94 per share a year ago. These
Eni Beats on Q1 Earnings & Revenues, Lowers '25 Capex Guidance
Eni S.p.A E reported first-quarter 2025 adjusted earnings from continuing operations of 92 cents per American Depository Receipt, which beat the Zacks Consensus Estimate of 91 cents. The bottom line
Exelixis' Q1 Earnings: Will Cabometyx Maintain Momentum?
Investors will focus on lead drug Cabometyx’s performance when Exelixis EXEL reports first-quarter 2025 results shortly.
The Zacks Consensus Estimate for sales and earnings is pegged at $502.8
Centene Q1 Earnings Beat Estimates on Marketplace Business Strength
Centene Corporation CNC reported first-quarter 2025 adjusted earnings per share (EPS) of $2.90, which surpassed the Zacks Consensus Estimate by 22.9%. Moreover, the bottom line climbed 28% year over
AbbVie Beats on Q1 Earnings & Sales, Raises '25 EPS View
AbbVie Inc. ABBV reported first-quarter 2025 adjusted earnings per share (EPS) of $2.46, which beat the Zacks Consensus Estimate of $2.39. The reported EPS also exceeded the company’s guidance of
Phillips 66 Posts Wider-Than-Expected Q1 Loss on Lower Refining Volumes
Phillips 66 PSX reported first-quarter 2025 adjusted loss of 90 cents per share, wider than the Zacks Consensus Estimate of a loss of 77 cents. The bottom line declined from the year-ago quarter’s
MIND Technology Rises 25% Despite Q4 Earnings Down Y/Y
Shares of MIND Technology, Inc. MIND have gained 24.5% since the company reported its earnings for the quarter ended Jan. 31, 2025. This compares to the S&P 500 index’s 4.3% growth over the same
Sallie Mae Q1 Earnings & Revenues Beat Estimates, Expenses Decline
Sallie Mae SLM reported first-quarter 2025 earnings per share of $1.40, which outpaced the Zacks Consensus Estimate of $1.19. The bottom line increased from the prior-year quarter’s $1.27.
The
Ryder Q1 Earnings Surpass Estimates, Improve Year Over Year
Ryder System, Inc. (R) reported first-quarter 2025 earnings per share (EPS) of $2.46, which surpassed the Zacks Consensus Estimate of $2.40 and improved 15% year over year, reflecting higher
American Tower Gears Up for Q1 Earnings: What's in the Cards?
American Tower Corporation AMT is scheduled to release first-quarter 2025 results on April 29, before the opening bell. The company’s quarterly results are expected to reflect a year-over-year
Alphabet Earnings Beat: An Undervalued Tech Behemoth
Alphabet (GOOGL) remains one of the most compelling investment opportunities in large-cap tech today. With regulatory scrutiny and investor skepticism weighing on sentiment, contrasted by the
3 Factors Why Greenback May Remain Low Now: ETFs to Win
The U.S.-dollar-based exchange-traded fund Invesco DB US Dollar Index Bullish Fund UUP has lost about 7.9% so far this year (as of April 24, 2025). Below, we highlight a few reasons that could keep
Should You Buy Spotify Stock Ahead of Q1 Earnings Report?
Spotify Technology S.A. SPOT will report its first-quarter 2025 results on April 29, before the bell.
The Zacks Consensus Estimate for earnings in the to-be-reported quarter stands at $2.32 per
TotalEnergies to Report Q1 Earnings: What's in Store for the Stock?
TotalEnergies SE TTE is set to report its first-quarter 2025 results on April 30, before the opening bell. The company reported an earnings surprise of 1.60% in the last reported quarter. See the
Here's Why You Should Hold the GEHC Stock in Your Portfolio for Now
GE HealthCare Technologies, Inc. GEHC is well-poised for growth in the coming quarters, courtesy of its continued focus on innovations. The optimism, led by strong fourth-quarter 2024 performance
Integer Holdings Q1 Earnings & Revenues Beat Estimates, Margins Expand
Integer Holdings Corporation ITGR delivered adjusted earnings per share (EPS) of $1.31 in the first quarter of 2025, which improved 14.9% year over year. The figure topped the Zacks Consensus
3 Reasons Why Growth Investors Shouldn't Overlook AZZ (AZZ)
Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. But finding a growth stock
Here is Why Growth Investors Should Buy BGC Group (BGC) Now
Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. But finding a great growth
Here is Why Growth Investors Should Buy Boston Scientific (BSX) Now
Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. But finding a great


